Login
$TRAW
$0.26 +$0.00 (0.0%) After hours

$TRAW 8-K/A SEC Filings

Filed On Filing
17 Jun 2024 8-K/A: Financial Statements and Exhibits

We have audited the accompanying balance sheets of Trawsfynydd Therapeutics, Inc. (the “Company”) as of December 31, 2023 and 2022, and the related statements of operations, redeemable convertible preferred stock and stockholders’ defici...

05 Aug 2021 8-K/A: Departure/Election of Directors or Officers; Compensation

On August 2, 2021, the Compensation Committee of the Board of Directors (the “Compensation Committee”) of the Company approved (i) stock option awards to purchase the Company’s common stock (the “Options”) and (ii) restricted stock unit ...

04 Mar 2021 8-K/A: Submission of Matters to a Vote of Security Holders; Other Events

On March 4, 2021, the Company held the Special Meeting. At the Special Meeting, the Company’s stockholders voted on the following proposal:

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support